Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2020.644690 Oncology Retraction Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA Frontiers Editorial Office *

Approved by: Giuseppe Giaccone, Cornell University, United States

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology

 15 01 2021 2020 10 644690 21 12 2020 21 12 2020 Copyright © 2021 Frontiers Editorial Office 2021 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research article The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA by Zhang L, Deng Y, Zhang Y, Liu C, Zhang S, Zhu W, Tang Y and Deng N (2020). Front. Oncol. 10:1190. doi: 10.3389/fonc.2020.01190

Following publication, concerns were raised regarding the integrity of Figures 3B and 3D. An investigation was conducted in accordance with Frontiers guidelines and the authors failed to provide a satisfactory explanation.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers.